NCT00518180 - A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents | Biotech Hunter

Enrollment

1,620

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

October 31, 2008

Conditions

Meningococcal MeningitisHuman Papillomavirus InfectionPertussisTetanus

Interventions

BIOLOGICAL

Novartis Meningococcal ACWY Conjugate Vaccine

One dose of vaccine administered intramuscularly

BIOLOGICAL

Tdap Vaccine

One dose of vaccine administered intramuscularly

BIOLOGICAL

Novartis Meningococcal ACWY Conjugate Vaccine

One dose of vaccine administered intramuscularly

Trial Locations (1)

San Jose, Costa Rica, San José